MINAPHARM Pharmaceuticals reported earnings results for the first quarter ended March 31, 2022. For the first quarter, the company reported sales was EGP 799.25 million compared to EGP 772.7 million a year ago. Net income was EGP 130.51 million compared to EGP 119.89 million a year ago. Basic earnings per share from continuing operations was EGP 10.24 compared to EGP 9.37 a year ago.